BridgeBio Pharma, Inc. 13D and 13G filings for EIDOS THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-26 09:00 am Sale |
2021-01-26 | 13D | EIDOS THERAPEUTICS INC EIDX |
BridgeBio Pharma Inc. BBIO |
1,000 100.000% |
-24,574,501 (-100.00%) |
Filing |
| 2020-10-05 5:30 pm Unchanged |
2020-10-05 | 13D | EIDOS THERAPEUTICS INC EIDX |
BridgeBio Pharma Inc. BBIO |
24,575,501 63.700% |
0 (Unchanged) |
Filing |